MedTrace Logo

Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults

NCT03435718 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2023-11-08

No results posted yet for this study

Summary

The main objective of this study is to provide data on the efficacy profile of different doses of oxfendazole when used in Trichuris trichiura infection. The drug will be also be examined for efficacy against other common nematodes encountered in man (Ascaris lumbricoides, Ancylostoma duodenale, Necator americanus). The study will also provide data on the safety and tolerability of the oxfendazole in patients.

Conditions

  • Trichuris Infection

Interventions

DRUG

Oxfendazole

oral suspension

DRUG

Albendazole

tablet

Sponsors & Collaborators

  • Universidad Peruana Cayetano Heredia, Lima, Peru

    collaborator UNKNOWN

  • Oxfendazole Development Group

    lead OTHER

Principal Investigators

  • Héctor Hugo Garcia, MD PhD · Oxfendazole Development Group

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-31
Primary Completion
2026-07-31
Completion
2026-10-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03435718 on ClinicalTrials.gov